[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "La Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. The company was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 54, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2025, "totalPay": 752482, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 48, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2025, "totalPay": 474737, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.19, "open": 2.23, "dayLow": 2.23, "dayHigh": 2.4999, "regularMarketPreviousClose": 2.19, "regularMarketOpen": 2.23, "regularMarketDayLow": 2.23, "regularMarketDayHigh": 2.4999, "payoutRatio": 0.0, "beta": -1.232, "forwardPE": -0.1896827, "volume": 153209, "regularMarketVolume": 153209, "averageVolume": 385733, "averageVolume10days": 1849060, "averageDailyVolume10Day": 1849060, "bid": 2.15, "ask": 2.25, "bidSize": 1, "askSize": 1, "marketCap": 3453619, "fiftyTwoWeekLow": 2.19, "fiftyTwoWeekHigh": 311.36, "allTimeHigh": 13462613.0, "allTimeLow": 2.19, "fiftyDayAverage": 16.9136, "twoHundredDayAverage": 39.08, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -4704380, "profitMargins": 0.0, "floatShares": 1402242, "sharesOutstanding": 1445029, "sharesShort": 25026, "sharesShortPriorMonth": 13701, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.050300002, "heldPercentInsiders": 0.03746, "heldPercentInstitutions": 0.00332, "shortRatio": 0.15, "shortPercentOfFloat": 0.050300002, "impliedSharesOutstanding": 1445029, "bookValue": 12.072, "priceToBook": 0.19797881, "lastFiscalYearEnd": 1767139200, "nextFiscalYearEnd": 1798675200, "mostRecentQuarter": 1767139200, "netIncomeToCommon": -11956000, "trailingEps": -121.8, "forwardEps": -12.59999, "lastSplitFactor": "1:28", "lastSplitDate": 1769385600, "enterpriseToEbitda": 0.393, "52WeekChange": -0.9895613, "SandP52WeekChange": 0.14272952, "quoteType": "EQUITY", "currentPrice": 2.39, "targetHighPrice": 1007.9996, "targetLowPrice": 279.99988, "targetMeanPrice": 643.99976, "targetMedianPrice": 643.99976, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 8229000, "totalCashPerShare": 5.695, "ebitda": -11973000, "totalDebt": 71000, "quickRatio": 3.114, "currentRatio": 3.251, "debtToEquity": 1.182, "returnOnAssets": -1.03931, "returnOnEquity": -2.38167, "freeCashflow": -5468625, "operatingCashflow": -10186000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1770425780, "regularMarketTime": 1770411602, "exchange": "NCM", "messageBoardId": "finmb_136941170", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 9.13242, "regularMarketPrice": 2.39, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "postMarketChangePercent": 3.2928796, "postMarketPrice": 2.4687, "postMarketChange": 0.07869983, "regularMarketChange": 0.2, "regularMarketDayRange": "2.23 - 2.4999", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 385733, "fiftyTwoWeekLowChange": 0.20000005, "fiftyTwoWeekLowChangePercent": 0.09132422, "fiftyTwoWeekRange": "2.19 - 311.36", "fiftyTwoWeekHighChange": -308.96997, "fiftyTwoWeekHighChangePercent": -0.99232394, "fiftyTwoWeekChangePercent": -98.95613, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -121.8, "epsForward": -12.59999, "epsCurrentYear": -48.85998, "shortName": "GRI Bio, Inc.", "longName": "GRI Bio, Inc.", "marketState": "CLOSED", "priceEpsCurrentYear": -0.04891529, "fiftyDayAverageChange": -14.523601, "fiftyDayAverageChangePercent": -0.8586936, "twoHundredDayAverageChange": -36.690002, "twoHundredDayAverageChangePercent": -0.9388434, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Vallon Pharmaceuticals, Inc.", "nameChangeDate": "2026-02-06", "cryptoTradeable": false, "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]